iFlash-2019-nCoV Antigen Test

It applies the chemiluminescent immunosassay (CLIA) for the qualitative detection of SARS-COV-2 antigen in nasal swab or nasopharyngeal swab.
Category
COVID-19
Product Overview

YHLO iFlash-2019-nCoV Antigen Test applies the chemiluminescent immunosassay for the qualitative detection of SARS-COV-2 antigen in nasal swab or nasopharyngeal swab, which may deliver a reliable and accurate result with high sensitivity and specificity.

Further more, as a fully automated and market-leading chemiluminescent analyzer, iFlash 1800/3000 is able to improve assay performance and avoid cross-infection to ensure the bio-safety during the whole operation.

Features:

Reliable Result: High Sensitivity and Specificity

High Throughput: Up to 300 T/h

Full Automation: Automated workflow reduces manual operation and avoids cross-infection to make the operators safety.

Reputation: iFlash CLIA solutions have been applied and evaluated by more than one hundred of published academic studies.

Language
Search
亚辉龙

Join Us

关注我们

Wechat

Headquarter: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China

Follow YHLO

wechatwechat wechat wechat wechat

© 2020  Shenzhen YHLO Biotech Co., Ltd.  All rights reserved.  粤ICP备19040167号